Enhanced limonene production by optimizing the expression of limonene biosynthesis and MEP pathway genes in  by unknown
Du et al. Bioresources and Bioprocessing 2014, 1:10
http://www.bioresourcesbioprocessing.com/content/1/1/10RESEARCH Open AccessEnhanced limonene production by optimizing the
expression of limonene biosynthesis and MEP
pathway genes in E. coli
Fu-Liang Du, Hui-Lei Yu, Jian-He Xu and Chun-Xiu Li*Abstract
Background: Limonene is an important monoterpene used as a chemical commodity and precursor for producing
biofuels, flavor and medicinal compounds.
Results: In this paper, we engineered Escherichia coli by embedding two exogenous genes encoding a limonene
synthase (LS) and a geranyl diphosphate synthase (GPPS) for production of limonene. Out of 12 E. coli strains
transformed with various plasmids, the best one with p15T7-ls-gpps produced limonene with a titer of 4.87 mg/L. In
order to enhance the limonene production, two rate-limiting enzymes in the endogenous MEP pathway of E. coli,
1-deoxy-xylulose-5-phosphate synthase (DXS) and isopentenyl diphosphate isomerase (IDI), were overexpressed
consecutively on vector pET21a+, resulting in a production of 17.4 mglimonene/L at 48 h.
Conclusions: After the preliminary optimization of the medium in a two-phase culture system composed of n-hex-
adecane (1/50, Vorg/Vaq), the final production of limonene was raised up to 35.8 mg/L, representing approximately a
7-fold improvement compared to the initial titer.
Keywords: Limonene; Biosynthesis; Escherichia coli; MEP pathway; Geranyl pyrophosphate synthase; Limonene
synthase; Two-phase culture systemBackground
Terpenoid, which has more than forty thousand kinds of
chemicals, is the largest family of natural products [1].
Limonene, one of the simplest monocyclic p-menthane
(1-methyl-4-isopropylcyclohexane) type monoterpenes,
has been used as a flavor or fragrance with aroma value
[2,3]. Limonene is also an important plant monoterpene
precursor of several fine chemicals, flavorings, fragrances,
and pharmaceuticals such as carveol, carvone, perillyl al-
cohol and menthol [2-6]. In addition, the hydrogenated
form of limonene can be used as fuel [7]. However, the
major supply of limonene is limited to plant sources
currently. Although chemical processes for monoterpene
synthesis have been well documented, very few pathway-
engineered processes [3,4] have been reported so far for
the production of limonene. Therefore, it is promising and* Correspondence: chunxiuli@ecust.edu.cn
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in any medium, provided the original work is pattractive to develop a route of microbial synthesis for lim-
onene production.
Isopentenyl diphosphate (IPP) and its isomer dimethylal-
lyl diphosphate (DMAPP) are the two essential building
blocks to synthesize all isoprenoids (terpenoids). There are
two biosynthetic pathways to produce IPP and DMAPP.
The first one is mevalonate pathway (MVA pathway)
present in all higher eukaryotes such as Saccharomyces cer-
evisiae [8-10] The second one is MEP pathway starting with
the reaction between pyruvate and glyceraldehyde-3-
phosphate to synthesize IPP and DMAPP [9,11]. Plants
produce their terpenoids using MEP pathway, which takes
place in their plastids. In addition, MEP pathway occurs in
most bacteria including Escherichia coli.
Based on the IPP and DMAPP produced from the MEP
pathway, limonene can be synthesized by the catalysis of
two key enzymes [4,12], geranyl diphosphate synthase
(GPPS) and limonene synthase (LS), which were reported
to occur in Abies grandis [13] and Mentha spicata [2], re-
spectively. GPPS catalyzes the condensation between IPP
and DMAPP, forming a linear diphosphate intermediate,pen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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terpenes. On the other hand, LS catalyzes the intramo-
lecular cyclization of GPP to give limonene (Figure 1).
Although overexpression of rate-limiting enzymes in the
MEP pathway has been used to produce many terpenoids
including isoprene, taxol precursor and levopimaradiene
[14-19], this method has not been used in the most com-
mon engineered strain Escherichia coli to produce limon-
ene. In a previous study, an engineered Escherichia coli,
harboring a heterologous GPPS gene from Abies grandis
and a LS gene from Mentha spicata, was reported to pro-
duce limonene in a titer of merely 5 mg/L (24 h) [4]. A
possible reason for the low limonene production might be
the insufficient supply of IPP and DMAPP. In another re-
port, an engineered Escherichia coli in which a heterol-
ogous MVA pathway was installed, can produce limonene
with titers around 335 mg/L at 48 h [3].
In this paper, we engineered E. coli to produce
(−)-limonene by expressing a GPPS, a LS, a 1-deoxy-d-
xylulose-5-phosphate synthase (DXS) and an isopentenyl
diphosphate isomerase (IDI). A series of modifications to
optimize the expression of those enzymes and the medium
have been done. The final production of limonene was
raised up to 35.8 mg/L, representing approximately a
7-fold improvement compared to the initial titer.
Methods
Bacterial strains, genes and vectors
Escherichia coli BL21 (DE3) (Novagen, Germany) was
used for gene cloning and expression. Escherichia coli
K12 MG1655 was used for amplification of dxs, idi,
and ispA genes. The gene sequences of GPPS and LS
were obtained from Abies grandis and Mentha spicata
(Genbank accession numbers: AF513112 and L13459).
These genes were condon optimized for E. coli andFigure 1 Engineered pathway for (−)-limonene biosynthesis in E. coli.
pathway in E. coli and the exogenous limonene biosynthesis pathway. DXS: 1
isomerase.commercially synthesized in Generay (Shanghai, China).
N-Terminal amino acids at positions 87 and 56 of GPPS
and LS (plastid transit peptide) were removed [13,20].
Vectors pET-21a, pET-28a, pACYCDuet-1, pQE30 and
pTrcHis2B (Novagen, Germany) were used for gene
expression.Genes cloning and plasmids construction
The PCR fragments of gpps and ls were cloned into the
BamHI–EcoRI and EcoRI–SalI sites of the pTrcHis2B
vector to create p40Trc-ls-gpps and p40Trc-gpps-ls plas-
mids. The generated ls-gpps and gpps-ls operons from
p40Trc-ls-gpps and p40Trc-gpps-ls were then cloned into
pACYCDueT-1 vector through BamH I and Sal I sites to
generate p15T7-ls-gpps and p15T7-gpps-ls plasmids. For
constructing p40T7-ls-gpps and p40T7-gpps-ls plasmids,
initially the operons ls-gpps and gpps-ls were inserted into
pET-28a vector at BamH I and Sal I sites. The ispAS80F,
which is designated as EcGPPS here, is another geranyl
pyrophosphate synthase. The method for constructing
plasmids p40Trc-ls-Ecgpps, p40Trc-Ecgpps-ls, p15T7-ls-
Ecgpps, p40T7-ls-Ecgpps, p40T7-Ecgpps-ls and p15T7-
Ecgpps-ls was the same as the plasmids listed above. The
dxs-idi operon was initially constructed by cloning each
of the genes from the genome of E. coli K12 MG1655.
The dxs-idi operon was cloned into pTrcHis2B vector
by the BamH I-Kpn I sites to create p40Trc-dxs-idi
plasmid. The dxs-idi operon was sub-cloned into the
pQE30 and pET-21a vectors through BamH I and Sal I
sites to construct p40T5-dxs-idi and p40T7-dxs-idi
plasmids, respectively. The primers used were listed in
Table 1. All plasmids in this study were shown in Table 2,
and all engineered E. coli strains and the corresponding
plasmids were shown in Table 3.(−)-Limonene was biosynthesized via glycolysis, the endogenous MEP
-Deoxy-d-xylulose-5-phosphate synthase; IDI: Isopentenyl diphosphate
Table 1 The plasmids constructed in this study
Plasmids Parent plasmids Copies Promoter Antibiotic marker Expression strength
p40Trc-ls-gpps pTrcHis2B 40 Trc ampicillin 40
p15T7-ls-gpps pACYCDuet-1 15 T7 chloramphenicol 75
p40T7-ls-gpps pET28a+ 40 T7 kanamycin 200
p40Trc-gpps-ls pTrcHis2B 40 Trc ampicillin 40
p15T7-gpps-ls pACYCDuet-1 15 T7 chloramphenicol 75
p40T7-gpps-ls pET28a+ 40 T7 kanamycin 200
p40Trc-ls-Ecgpps pTrcHis2B 40 Trc ampicillin 40
p15T7-ls-Ecgpps pACYCDuet-1 15 T7 chloramphenicol 75
p40T7-ls-Ecgpps pET28a+ 40 T7 kanamycin 200
p40Trc-Ecgpps-ls pTrcHis2B 40 Trc ampicillin 40
p15T7-Ecgpps-ls pACYCDuet-1 15 T7 chloramphenicol 75
p40T7-Ecgpps-ls pET28a+ 40 T7 kanamycin 200
p40T7-dxs-idi pET21a+ 40 T7 ampicillin 200
p40T5-dxs-idi pQE30 40 T5 ampicillin 80
p40Trc-dxs-idi pTrcHis2B 40 Trc ampicillin 40
The expression strengths of vectors were estimated using published values of promoter strength and copy number. Promoter strengths were calculated as Trc = 1, T5 = 2,
T7 = 5 (Brosius et al. [21], Brunner et al. [22]). Gene copy number was assigned by published copy numbers for origin of replication for the different plasmids used.
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Culture for limonene production was carried out in 2YT
medium using a shaking incubator at 20°C and 180 rpm.
Glycerol as the main carbon source, was added at 2%
(w/v) concentration to all the media used in this study
[23]. LB medium and TB medium were compared withTable 2 List of engineered E. coli strains and the
corresponding plasmids







1 - 1 p40Trc-ls-gpps 40
2 - 1 p15T7-ls-gpps 75
3 - 1 p40T7-ls-gpps 200
4 - 1 p40Trc-gpps-ls 40
5 - 1 p15T7-gpps-ls 75
6 - 1 p40T7-gpps-ls 200
7 - 1 p40Trc-ls-Ecgpps 40
8 - 1 p15T7-ls-Ecgpps 75
9 - 1 p40T7-ls-Ecgpps 200
10 - 1 p40Trc-Ecgpps-ls 40
11 - 1 p15T7-Ecgpps-ls 75
12 - 1 p40T7-Ecgpps-ls 200
13 p40T7-dxs-idi 200 p15T7-ls-gpps 75
14 p40T5-dxs-idi 80 p15T7-ls-gpps 75
15 p40Trc-dxs-idi 40 p15T7-ls-gpps 75
For a full plasmids description, see Table 1.2YT medium as basis media for limonene production.
The addition of pyruvate as an auxiliary carbon source
has been reported to increase terpenoid production
[24]. Ampicillin (100 μg/mL), kanamycin (50 μg/mL)
and chloramphenicol (50 μg/mL) were added to the
culture as required. Cell culture was carried out in
100 mL of medium, and growth was determined by
measuring the optical density at 600 nm (OD600). For
the two-phase culture for limonene production, IPTG
was added when OD600 reached about 0.7, and 2 mL of
n-hexadecane was layered over 100 mL of culture
medium. The assay for glycerol was conducted by the
Nash reagent [25].Analysis of limonene
In the two-phase culture system with n-hexadecane over-
lay, limonene was extracted with the upper n-hexadecane
phase. Then n-hexadecane containing the limonene
was collected and centrifuged at 14,000 rpm for
10 min. The n-hexadecane extracts were analyzed with
GC-MS (QP2010, Shimadzu, Kyoto, Japan) equipped
with an InertCap DB-5 ms column. Limonene from
splitless 1 μL injection was separated using a GC oven
temperature program of 50°C for 3 min, followed by a
10°C/min ramp to 250°C. Injector and MS quadrupole
detector temperatures were 250°C and 150°C, respect-
ively. To increase the sensitivity and selectivity of detec-
tion, the MS was operated in selected ion-monitoring
(SIM) mode using ions of 136, 68, and 93 m/z, which
represent the molecular ion and two abundant fragmental
ions of limonene.
Table 3 Primers used in this work
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Optimizing the expression of limonene biosynthesis
genes in E. coli
(−)-Limonene can be produced by introducing the gpps and ls
genes into E. coli. Previously, IspAS80F has been known to
make the ispA variant synthesize GPP only [26]. We cloned
the ispA genes from E. coli, and got the IspAS80F gene Ecgpps.
Polycistronic operons consisting of gpps and ls or Ecgpps and
ls, in which the genes can be assembled as one transcriptional
unit, were constructed based on pTrcHis2B, pACYCDuet-1
and pET28a+. Then totally twelve limonene synthesis
plasmids were constructed (Table 2) and introduced into the
E. coli, respectively. Those twelve recombinant E. coli cell lines,
each harboring one limonene biosynthesis plasmid, were
cultured in 2YT medium for 48 h. The cells were cultured
with 250 μM IPTG induction. As shown in Figure 2, only
trace amounts of limonene were detected in the culture of
E. coli harboring Ecgpps-ls operon or gpps-ls operon. While
the four recombinant strains harboring ls-Ecgpps operon and
ls-gpps operon (strain #2, #7, #8 and #9) could produce a quite
significant amount of limonene, indicating that the limonene
synthase gene should be put before the gene of geranyldiphosphate synthase when they were coexpressed in one
plasmid. Moreover, the strain #2 harboring the ls-gpps operon
could produce more limonene than the other strains (strain
#7, #8 and #9) harboring the ls-Ecgpps operon. This result
showed that GPPS was more suitable for monoterpene
biosynthesis compared to EcGPPS. In addition, for the better
expression of ls-gpps operon, a moderate expression strength
(Table 2) was good for E. coli to produce limonene. We also
found that the cell mass was greatly associated with the limon-
ene production (Figure 2, C). This phenomenon indicated that
the expression of plasmid p15T7-ls-gpps, which could affect
the main metabolism, was conducive to cell growth. As a
result, the limonene synthesis plasmid p15T7-ls-gpps was
therefore selected for limonene production in further
experiments. This optimized limonene pathway plasmid
could lead the recombinant E. coli to accumulate 4.87 mg/L
of limonene or 0.863 mg/gDCW after 48 h of cultivation.
Overexpression of rate-limiting enzymes in the endogenous
MEP pathway
The limonene building blocks, IPP and DMAPP, can be
synthesized in E. coli via the endogenous MEP pathway.
BC
A 
Figure 2 Optimization of the expressions of limonene biosynthesis
genes in E. coli. For a full description of the polycistronic operons
and the vectors, see Table 3. A: Total production (mg/L); B: Specific




Figure 3 Overexpression of two rate-limiting enzymes in the
endogenous MEP pathway to supply building blocks. For a
full description of the strains and their plasmids, see Table 3 and
Table 1, respectively. A: Total production (mg/L). B: Specific production
(mg/gDCW); C: Cell mass (gDCW/L).
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ported as the most critical rate-limiting step in the en-
dogenous MEP pathway of E. coli [27-30]. In this study,
the polycistronic operon dxs-idi was constructed based on
pTrcHis2B, pQE30 and pET21a + to form p40Trc-dxs-idi,
p40T5-dxs-idi and p40T7-dxs-idi. These three plasmids
were respectively introduced into the strain #2, resulting
in another three strains designated as strains #13, #14 and
#15. Then the strains #2, #13, #14 and #15 were cultured
in 2YT medium for 48 h. Various inducer (IPTG) concen-
trations, from 10 μM to 500 μM, were also evaluated. As
shown in Figure 3, the strain #13 containing both plas-
mids p40T7-dxs-idi and p15T7-ls-gpps could accumulate
limonene up to 17.4 mg/L (or 2.89 mg/gDCW) after 48 hcultivation with IPTG induction at 50 μM, which re-
presents approximately a 3.6-fold enhancement in total
limonene production (from 4.87 to 17.4 mg/L) or a 3.3-
fold improvement in specific production (from 0.863 to
2.89 mg/gDCW). Meanwhile the cell mass was the largest.
Additionally, limonene production significantly affected
the cell mass and glycerol consumption (Figure 3C, D).
Clearly, the higher productivity and more robust growth
of strain #13 allowed higher limonene accumulation. Fur-
ther improvements should be possible through medium
optimization.
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production
Besides the genetic modulation described above, we also
optimized the growth medium to further increase the lim-
onene productivity. E. coli strain #13 was respectively cul-
tured in 2YT, LB or TB media. The limonene production
was measured after 24 h, 48 h and 72 h cultivation. Al-
though the three media had no significant differences in
the specific production of limonene, 2YT medium gave
higher titers than the other two media (Figure 4). So 2YT
medium was chosen as the basis medium for the cultiva-
tion of genetically engineered strain #13. In a previous
work [24], pyruvate and dipotassium phosphate were
found beneficial for isoprenoid production in E. coli.
Therefore, the 2YT medium supplemented with different
concentrations of pyruvate was designed and employed
for the culture of strain #13. As shown in Figure 5,
addition of 4 g/L pyruvate could stimulate the limonene
production of up to 15.1 mg/L or 4.11 mg/gDCW after
24 h cultivation, 32.5 mg/L or 5.59 mg/gDCW after 48 h,
and 35.8 mg/L or 5.76 mg/gDCW after 72 h. Although the
cell mass was basically the same (Figure 5, C), it is ap-
proximately a 2-fold increase in limonene production as
compared with the un-optimized medium used in this
work or a 7-fold increase in contrast to the initial titer
(4.87 mg/L). Meanwhile, the consumption of glycerol wasFigure 4 Effect of culture medium on limonene production of the str
C: Cell mass (gDCW/L); D: Glycerol in medium (g/L).also the largest (Figure 5, D). In addition, the effect of
K2HPO4 was also examined (data not shown), although
the improvement was not so significant as pyruvate.
Discussion
In this paper, we significantly increased the limonene
yield in E. coli by optimizing the expression of the two
limonene biosynthesis genes, overexpression of the two
rate-limiting enzymes in the endogenous MEP pathway,
and optimization of the culture medium (Figure 6). We
established a limonene biosynthesis pathway in E. coli using
four different polycistronic operons based on three vectors
with varied expression strength. Previous researches on
limonene biosynthesis focused merely on the expression
of a certain polycistronic operon (e.g., gpps-ls) based on a
specified vector [3,4]. In addition, only the GPPS from
plant Abies grandis was tried for limonene production
[3,4]. In this study, Ecgpps, a bacterial gpps gene that is
native to E. coli, was tried for the first time for limonene
production. Previous study indicated that limonene bio-
synthesis pathway flux was limited by the inherently low
enzyme activity of the plant-originated GPPS [4]. How-
ever, our result showed that the protein-engineered
EcFPPSS80F from E. coli also suffers a problem of low activ-
ity for limonene production. The two genes connected by
IRES sequences can be expressed from a single promoterain #13. A: Total production (mg/L); B: Specific production (mg/gDCW);
A C
B D
Figure 5 Effect of pyruvate concentration on limonene production of the strain #13. A: Total production (mg/L); B: Specific production
(mg/gDCW); C: Cell mass (gDCW/L); D: Glycerol in medium (g/L).
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pression system, the gene ranked in front will be tran-
scripted and translated primarily, followed by the
transcription and translation of the subsequent gene in
the polycistronic operons [31]. So the order of the limiting
genes in polycistronic operons has a lot to do with the ex-
pression of the genes and the quantity of final product
[14,15,32]. Our result showed that those E. coli strains ex-
pressing ls-gpps or ls-Ecgpps produced larger amounts of
limonene than the strains expressing gpps-ls or Ecgpps-ls.
This result disputes the current notion that the order ofFigure 6 Progressive enhancement of limonene production in E. coli. Th
the limonene biosynthesis genes expression; overexpression of rate-limiting ethe limiting genes in polycistronic operons should corres-
pond to that of terpenoid metabolic pathway in the nat-
ural and fine regulation mechanism of microorganisms
[19]. In addition, the expression strength of vectors used
for limonene biosynthesis was also indicated to be a very
important determinant for the final limonene yield.
Our work represents the first report on limonene bio-
synthesis via overexpression of rate-limiting enzymes in
MEP pathway. When the two limiting genes (dxs & idi)
were coexpressed, both the expression strength and IPTG
concentration were very important for achieving a highe limonene yield of E. coli was increased by three steps: Optimization of
nzymes in the endogenous MEP pathway; and medium adjustment.
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expressed on various vectors, which resulted in different
limonene productions. This phenomenon was also re-
ported in the researches on taxadiene and levopimara-
diene biosynthesis [14,15]. Once again, an appropriate
expression strength of genes made tremendous contri-
bution to the overall yield of the final product. Although
a direct comparison of limonene yield with previous
studies on isoprene or terpenoid is difficult because of
the differences in products and assay conditions used,
our results agree well with the published values of in-
creases in isoprene or terpenoid yields when overex-
pressing enzymes of MEP pathway (Table 4). Although
it might have become a popular point that the MEP
pathway is not effective for high-level production of ter-
penoid [9,33], the MEP pathway is a native pathway and
the stoichiometry of MEP pathway is more efficient as
compared to MVA pathway for IPP/DMAPP synthesis
[34]. The limonene production by the MEP pathway in
this work was much lower than the reported result by
the MVA pathway [3]. It was partly because only two
bottleneck enzymatic steps (dxs and idi) were targeted
to increase the flux through the MEP pathway. Previous
work [35] revealed that ispB, ispD and ispF also produce
rate-limiting enzymes impacting the MEP flux. Second,
previous results showed that the expression of B. subti-
lis bottleneck enzymes in E. coli resulted in an enhance-
ment of total isoprene production [17]. The low enzyme
activity and the native regulation of the native bottle-
neck enzymes might be the reasons of low limoneneTable 4 The terpenoid production increased in this study and
Products Production increased Genes
Isoprene 0.4-fold dxs and
Phytoene 2.1-fold idi
Isoprene 2.3-fold dxs and
β-Carotene 2.7-fold idi
Abietadiene 2.8-fold dxs, dxr
Squalene 2.9-fold dxs and
Limonene 3.4-fold dxs an
Carotenoids 3.5-fold dxs, dxr
Isoprene 4.0-fold dxs, isp
Lycopene 4.5-fold idi
Isoprene 4.8-fold dxs, dxr
Taxadiene 15.6-fold dxs, idi
Levopimaradiene 611.3-fold dxs, idi
The rate-limiting enzymes in the MEP pathway were overexpressed in all the studie
aThe gene of 1-deoxy-d-xylulose-5-phosphate reductoisomerase;
bThe gene of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate synthase;
cThe gene of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate reductase;
dThe gene of 4-diphosphocytidyl-2-c-methyl-d-erythritol kinase;
eThe gene of 2-c-methyl-d-erythrtol-4-phosphate cytidyltransferase;
fThe gene of 2-c-methyl-d-erythritol 2, 4-cyclodiphosphate synthase.production in this work. Third, different E. coli strains
might result in the difference in limonene biosynthesis.
E. coli BL21 (DE3) might not be as suitable as E. coli
DH1 for terpene biosynthesis [3].
Besides genetic modulations, we also systematically opti-
mized the culture medium to further increase limonene
production. Pyruvate and dipotassium phosphate were
chosen as supplements. The addition of pyruvate as the
auxiliary carbon source has been reported to increase ter-
penoid production [24]. Since pyruvate was the immediate
precursor of MEP pathway, the addition of pyruvate
greatly increased the DMAPP synthesis so as to signifi-
cantly enhance the limonene production. In addition, the
addition of pyruvate affects the main metabolism. Namely,
keto-acid such as pyruvate, OAA, and 2KG etc. affect Cya
and in turn affect cAMP level. In the case of using glycerol
as a carbon source, cAMP-Crp level is high in the wild
type, while this may be decreased when pyruvate was
added, and thus the glycerol consumption rate may be
affected, since glpFKD is under control of cAMP-Crp.
Dipotassium phosphate was also found to be beneficial
for limonene production in E. coli. It supports the results
of the previous study on terpenoid biosynthesis [24].
To prevent limonene volatilizing and to extract it from
the culture medium, a two-phase culture system composed
of n-hexadecane was adopted in this study. Hexadecane
was chosen for its high hydrophobicity (log PO/W, 8.8) for
the extraction of limonene, and low volatility, which pre-
vents loss due to evaporation. A ratio of 1/50 (Vorg/Vaq,
2 mL of hexadecane was layered over 100 mL of cultureprevious studies
overexpressed References
dxra Xue et al. [16]
Kajiwara et al. [36]
dxr Zhao et al. [17]
Kajiwara et al. [36]
and idi Morrone et al. [33]
idi Ghimire et al. [37]
d idi This work
and idi Albrecht et al. [38]
Gb, ispHc, idi, ispEd, dxr, ispDe and ispFf Zurbriggen et al. [18]
Kajiwara et al. [36]
and idi Lv et al. [19]
ispD and ispF Ajikumar et al. [14]
ispD and ispF Leonard et al. [15]
s listed in this table.
Du et al. Bioresources and Bioprocessing 2014, 1:10 Page 9 of 10
http://www.bioresourcesbioprocessing.com/content/1/1/10broth) was adopted in this two-phase culture system.
Limonene was extracted into the hexadecane phase, and
negligible amounts of limonene were detected in the cell
mass and culture broth (data not shown). As a result, lim-
onene production was measured only from the hexadecane
phase. The two-phase culture system using hydrophobic
and low volatile organic solvent was a very useful and com-
mon method used in terpenoid biosynthesis [3,14,15].
Conclusions
Although the limonene production was enhanced signifi-
cantly in this study, more efforts are still needed to
achieve a higher production and to make it more eco-
nomic. On one hand, the metabolic flux of the endogen-
ous MEP pathway can be enhanced by overexpressing
the rate-limiting enzymes from other bacteria such as
Bacillus subtilis [17] and/or blocking the competing
metabolic pathways. On the other hand, the problem of
low GPPS/LS activities needs also to be addressed by di-
rected evolution or rational protein engineering. Besides,
the culture medium should be more efficient and eco-
nomic, and the metabolically engineered strain should
be cultivated in a bioreactor for commercial production
of limonene in the future.
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